NEU 3.76% $14.35 neuren pharmaceuticals limited

You could resonably argue that Q1+Q2 might be lower than 50%...

  1. 1,548 Posts.
    lightbulb Created with Sketch. 164
    You could resonably argue that Q1+Q2 might be lower than 50% given the Q4 effect.
    For example, if the phasing accross quarters for the year was 20%,25%,25%,30%, then I would think that Q2 sales would be closer to US$92m. (Q1 sales are close to the 20% example at US$75.9).
    Last edited by mjc159: 04/07/24
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$14.35
Change
0.520(3.76%)
Mkt cap ! $1.834B
Open High Low Value Volume
$13.96 $14.35 $13.66 $6.469M 457.9K

Buyers (Bids)

No. Vol. Price($)
3 2023 $14.27
 

Sellers (Offers)

Price($) Vol. No.
$14.38 1777 1
View Market Depth
Last trade - 16.10pm 26/09/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.